Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Beginning Balances at Dec. 31, 2022	$ 581,013	$ 128	$ 1,510,518	$ (5,438)	$ (924,195)
Beginning Balances (in shares) at Dec. 31, 2022		127,604
Issuance of common stock upon exercise of stock options, shares		244
Issuance of common stock upon exercise of stock options	1,617		1,617
Issuance of common stock upon release of restricted stock awards, net of statutory tax withholdings	(5,963)	$ 1	(5,964)
Issuance of common stock upon release of restricted stock awards, net of statutory tax withholdings, Shares		850
Issuance of common stock under Employee Stock Purchase Plan	777		777
Issuance of common stock under Employee Stock Purchase Plan (in shares)		81
Stock compensation expense	20,596		20,596
Total other comprehensive income (Loss)	66			66
Net Income (Loss)	(20,901)				(20,901)
Ending Balances at Jun. 30, 2023	577,205	$ 129	1,527,544	(5,372)	(945,096)
Ending Balances (in shares) at Jun. 30, 2023		128,779
Beginning Balances at Mar. 31, 2023	563,732	$ 128	1,516,331	(4,200)	(948,527)
Beginning Balances (in shares) at Mar. 31, 2023		128,472
Issuance of common stock upon exercise of stock options, shares		203
Issuance of common stock upon exercise of stock options	1,378		1,378
Issuance of common stock upon release of restricted stock awards, net of statutory tax withholdings	(726)	$ 1	(727)
Issuance of common stock upon release of restricted stock awards, net of statutory tax withholdings, Shares		104
Stock compensation expense	10,562		10,562
Total other comprehensive income (Loss)	(1,172)			(1,172)
Net Income (Loss)	3,431				3,431
Ending Balances at Jun. 30, 2023	577,205	$ 129	1,527,544	(5,372)	(945,096)
Ending Balances (in shares) at Jun. 30, 2023		128,779
Beginning Balances at Dec. 31, 2023	622,072	$ 130	1,554,634	(2,108)	(930,584)
Beginning Balances (in shares) at Dec. 31, 2023		129,530
Issuance of common stock upon exercise of stock options, shares		294
Issuance of common stock upon exercise of stock options	2,054		2,054
Issuance of common stock upon release of restricted stock awards, net of statutory tax withholdings	(8,575)	$ 1	(8,576)
Issuance of common stock upon release of restricted stock awards, net of statutory tax withholdings, Shares		1,066
Issuance of common stock under Employee Stock Purchase Plan	904		904
Issuance of common stock under Employee Stock Purchase Plan (in shares)		94
Stock compensation expense	26,532		26,532
Total other comprehensive income (Loss)	(2,803)			(2,803)
Net Income (Loss)	2,665				2,665
Ending Balances at Jun. 30, 2024	642,849	$ 131	1,575,548	(4,911)	(927,919)
Ending Balances (in shares) at Jun. 30, 2024		130,984
Beginning Balances at Mar. 31, 2024	618,480	$ 131	1,562,027	(4,373)	(939,305)
Beginning Balances (in shares) at Mar. 31, 2024		130,859
Issuance of common stock upon exercise of stock options, shares		54
Issuance of common stock upon exercise of stock options	419		419
Issuance of common stock upon release of restricted stock awards, net of statutory tax withholdings	(416)		(416)
Issuance of common stock upon release of restricted stock awards, net of statutory tax withholdings, Shares		71
Stock compensation expense	13,518		13,518
Total other comprehensive income (Loss)	(538)			(538)
Net Income (Loss)	11,386				11,386
Ending Balances at Jun. 30, 2024	$ 642,849	$ 131	$ 1,575,548	$ (4,911)	$ (927,919)
Ending Balances (in shares) at Jun. 30, 2024		130,984